课题基金 / 基金详情

Investigating LKB1-mediated inflammation as a mediator of tumour progression

Investigating LKB1-mediated inflammation as a mediator of tumour progression
研究 LKB1 介导的炎症作为肿瘤进展的介质
批准号:
368921
负责人:
Jones Russell G
金额:
$61.02万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01

项目摘要

项目成果

Jones Russell G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is now appreciated that the immune system plays an important role in controlling cancer progression. Recent work in understanding how T cells respond to the tumour microenvironment has led to transformative therapies - so called "immune checkpoint bloc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the regulation of lymphocyte function by metabolic reprogramming
  • 批准号:
    323719
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.64万
  • 财政年份:
    2015
  • 负责人:
    Jones Russell G
  • 依托单位:
Regulation of tumourigenesis and tumour cell metabolism by the energy sensor AMPK
  • 批准号:
    267445
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.09万
  • 财政年份:
    2012
  • 负责人:
    Jones Russell G
  • 依托单位:
Development of novel animal models to study the impact of metabolism on aging: Investigating the role of the AMP-activated protein kinase (AMPK)
  • 批准号:
    228752
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.61万
  • 财政年份:
    2010
  • 负责人:
    Jones Russell G
  • 依托单位:
Role of the AMP-activated protein kinase (AMPK) in stress resistance and cancer
海外基金